Posted by Michael Wonder on 06 Apr 2025
Update on US FDA BLA for Novavax’s COVID-19 vaccine
2 April 2025 - Novavax can confirm that 1 April 2025, was the US FDA’s Prescription Drug User Fee Act date for our biologics license application (BLA) seeking the approval of our COVID-19 Vaccine.
As of 1 April 2025 we had responded to all of the FDA’s information requests and we believe that our BLA is ready for approval.
